SAN FRANCISCO, CA—A novel percutaneous ventricular assist device (pVAD) appears to offer comparable safety to an intra-aortic balloon pump (IABP) when offering hemodynamic stabilization in elective, ...

High-risk patients undergoing a coronary procedure such as placement of a stent who electively received an intra-aortic balloon pump (a device that can help improve blood flow) prior to the procedure ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Long-term follow-up from the IABP-SHOCK II trial shows that the use of intra-aortic balloon pumps for ...

A percutaneous left ventricular assist device fails to offer improvement in 30-day outcomes compared with intra-aortic balloon pump (IABP) therapy in high-risk patients requiring hemodynamic support ...

Interv Cardiol. 2012;4(2):211-234. The future of IABC cannot, however, be taken in isolation. It must be analyzed in the context of other PCADs available for in-human use, namely the Impella Recover ...

An intra-aortic balloon pump is a temporary treatment to help the heart pump enough blood around the body, which people with certain heart conditions may require. An intra-aortic balloon pump (IABP) ...

The applicability and validity of registry data remains open to debate. When studying a patient cohort that is notoriously difficult to enroll in randomized trials, registry data can certainly add ...

High-risk patients undergoing a coronary procedure such as placement of a stent who electively received an intra-aortic balloon pump (a device that can help improve blood flow) prior to the procedure ...